Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Diabetic maculopathy].

M Ivanisević1

  • 1Klinika za ocne bolesti, KBC Firule, Split.

Lijecnicki Vjesnik
|September 1, 1992
PubMed
Summary
This summary is machine-generated.

Diabetic maculopathy, a major cause of vision loss from diabetic retinopathy, has limited drug therapies. Photocoagulation offers symptomatic benefit for specific types, alongside glycemic control and managing systemic conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PROF. DR CARL FERDINAND RITTER VON ARLT (1812-1887): HIS LIFE AND WORK DURING HIS OPHTHALMOLOGICAL CAREER IN PRAGUE.

Ceska a slovenska oftalmologie : casopis Ceske oftalmologicke spolecnosti a Slovenske oftalmologicke spolecnosti·2023
Same author

Albrecht Von Graefe's Ophthalmic Educational Visit to William Wilde in Dublin in 1851.

Irish medical journal·2020
Same author

Microsatellite variation of ESR1, ESR2, and AR in Serbian women with primary ovarian insufficiency.

Climacteric : the journal of the International Menopause Society·2018
Same author

Acute responses to structured aerobic and resistance exercise in women with gestational diabetes mellitus.

Scandinavian journal of medicine & science in sports·2018
Same author

[OPTICAL COHERENCE TOMOGRAPHY CHARACTERISTICS OF DIABETIC MACULAR OEDEMA].

Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti·2017
Same author

Effect of eicosapentaenoic acid and docosahexaenoic acid supplementation on C-peptide preservation in pregnant women with type-1 diabetes: randomized placebo controlled clinical trial.

European journal of clinical nutrition·2017
Same journal

[Satisfaction of young doctors in Croatia: are we heading in the right direction?}.

Lijecnicki vjesnik·2018
Same journal

[Empa-reg and leader trials -revolution in modern diabetology?].

Lijecnicki vjesnik·2018
Same journal

[AUTONOMIC DYSREFLEXIA].

Lijecnicki vjesnik·2018
Same journal

[ASSESSMENT OF QUALITY OF LIFE IN GLAUCOMA PATIENTS].

Lijecnicki vjesnik·2018
Same journal

[HBsAg SEROCONVERSION IN THE TREATMENT OF CHRONIC HEPATITIS B WITH PEGYLATED INTERFERON].

Lijecnicki vjesnik·2018
Same journal

[FEMUR FRACTURES IN CHILDREN – CAUSES AND MECHANISMS OF INJURY].

Lijecnicki vjesnik·2018
See all related articles

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Diabetic Retinopathy Research

Context:

  • Diabetic maculopathy is a primary cause of vision impairment in diabetic retinopathy patients.
  • It predominantly affects older individuals with non-insulin-dependent diabetes and nonproliferative diabetic retinopathy.
  • Maculopathy presents in exudative, edematous, and ischemic forms, with macular edema being the most prominent initial sign.

Purpose:

  • To review the current understanding and management of diabetic maculopathy.
  • To highlight the limitations of drug therapies and the role of photocoagulation.
  • To emphasize the importance of glycemic control and systemic disease management.

Summary:

  • No current drug therapies demonstrate efficacy for diabetic maculopathy.

Related Experiment Videos

  • Photocoagulation provides symptomatic improvement for edematous and exudative forms, maintaining or improving visual acuity.
  • Fluorescein angiography is crucial for identifying leakage and monitoring treatment outcomes.

    • Impact:

    • This review underscores the need for comprehensive management strategies for diabetic maculopathy.
    • It guides clinical practice by recommending photocoagulation for specific subtypes and emphasizing systemic health.
    • Improved patient outcomes rely on integrated care addressing both ocular and systemic factors in diabetes.